contact[at]op2lysis.com

pilelabs
  • The company
  • The Technology
  • Products
  • Indications
  • News
  • Contact
  • Français

Daily Archives: 7 December 2022

  1. Home
  2. 2022
  3. December
  4. 07
  • Jerôme Parcq
  • December 2022
  • Press Release
The EIC Accelerator grant agreement has been signed by the European Innovation Council and provides €2.5M support to the O2L-001 development programme

The European Innovation Council and SME Executive Agency (EISMA) has validated the EIC Accelerator grant contract and followed the initial recommandation of the independent jury by awarding us the maximum support, i.e. a grant of €2.5M to industrialise O2L-001. The press release:

Read More

Articles récents

  • Retrospective – 2022 in a nutshell
  • The EIC Accelerator grant agreement has been signed by the European Innovation Council and provides €2.5M support to the O2L-001 development programme
  • Orphan drug designation granted to OptPA for the treatment of non-traumatic spontaneous intracerebral hemorrhage by the European Commission
  • Who are we? Meet Audrey Thiebaut – R&D Project Manager
  • A large number of successes in 2021!

Archives

  • January 2023
  • December 2022
  • September 2022
  • April 2022
  • January 2022

Catégories

  • Corporate
  • Press Release
gym-footer-logo

Biotechnology company that researches and develops innovative medicines

SItemap

  • Contact
  • home
  • Indications
  • Legal Notice
  • News
  • Products
  • The company
  • The Technology

Recent Posts

Retrospective – 2022 in a nutshell
January 24, 2023
The EIC Accelerator grant agreement has been signed by the European Innovation Council and provides €2.5M support to the O2L-001 development programme
December 07, 2022

Contact

  • FRANCE: 117 avenue Victor Hugo, 92100 Boulogne-Billancourt, France BELGIUM: Légia Park, Boulevard Patience et Beaujonc, 3, 4000 Liège, Belgium

Op2Lysis © 2022 All Rights Reserved – Legal notice – web agency : Bridge Communication